Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection

AIDS

Volumn 11, Issue 3, 1997, Pages 289-295

  Wilkinson, Iain D ^a,e   Miller, Robert F ^b   Miszkiel, Katherine A ^b   Paley, Martyn N J ^c   Hall Craggs, Margaret A ^b   Baldeweg, Torsten ^d   Williams, Ian G ^b   Carter, Simon ^b   Newman, Stanton P ^b   Kendall, Brian E ^b   Catalan, José ^d   Chinn, Roger J S ^b   Harrison, Michael J G ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

HIV; Magnetic resonance spectroscopy; Natural history; Neurological

Indexed keywords

CHOLINE; CREATINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY;

BRAIN; CD4 LYMPHOCYTE COUNT; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 8044243588     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199703110-00005     Document Type: Article

References (31)

1. Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV: The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986, 124:537-558.
2. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
3. Everall IP, Luthert PI, Lantos P: Neuronal loss in the frontal cortex in HIV infection. Lancet 1991, 337:1119-1121.
4. Manji H, Connolly S, Mc Allister R, et al.: Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. J Neurol Neurosurg Psychiat 1994, 57:144-149.
5. Dooneief G, Bello I, Todak G, et al.: A prospective controlled study of magnetic resonance imaging of the brain in gay men and parental drug users with human immunodeficiency virus infection. Arch Neurol 1992, 49:38-43.
6. Sonnerborg A, Saaf J, Alexius B, Strannegard O, Wahlund LO, Wetterberg L: Quantitative detection of brain aberrations in human immunodeficiency virus type 1-infected individuals by magnetic resonance imaging. J Infect Dis 1990, 162:1245-1251.
7. Paley M, Chong WK, Wilkinson ID, et al.: Cerebrospinal fluid-intracranial volume ratio measurements in patients with HIV infection: CLASS image analysis technique. Radiology 1994, 190:879-886.
8. Wilkinson ID, Chinn RJS, Paley MNJ, et al.: Sub-cortical whitegrey matter contrast on MRI as a quantitative marker for diffuse HIV-related parenchymal abnormality. Clin Radiol 1996, 51:475-479.
9. Wilkinson ID, Paley M, Hall-Craggs MA, et al.: Cerebral magnetic resonance relaxometry in HIV infection. Magn Reson Imaging 1996, 14:365-372.
10. Iran-Dinh YR, Mamo H, Cervoni J, Caulin C, Saimol AC: Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med 1990, 31:1601-1607.
11. Rosci MA, Pigorini F, Bernabei A, et al.: Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1-infected subjects. AIDS 1992, 6:1309-1316.
12. Pascal S, Resnick L, Barker WW, et al.: Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med 1991, 32:1725-1729.
13. Nuwer MR, Miller EN, Vischer BR, et al.: Asymptomatic HIV infection does not cause EEC abnormalities: results from the multicenter AODS Cohort Study (MACS). Neurology 1992, 42:1214-1249.
14. Newton TF, Leuchter AF, Miller FN, Weiner H: Quantitative EEC in patients with AIDS and asymptomatic HIV infection. Clin Electroencephalogr 1994, 25:18-25.
15. Newman SP, Lunn S, Harrison MJG: Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS 1995, 9:1211-1220.
16. Gray F, Scaravilli F, Everall I. et al.: Neuropathology in early HIV-1 infection. Brain Pathol 1996, 6:1-15.
17. Menon DK, Ainsworth JG, Cox IJ, et al.: Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992, 16:538-542.
18. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I: Proton MR spectroscopy in HIV-infected patients: characterisation of abnormalities with imaging and clinical correlation. Radiology 1993, 186:739-744.
19. Meyerhoff DJ, MacKay S, Bachman L, et al.: Reduced brain N-acelylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in-vivo H magnetic resonance spectroscopic imaging. Neurology 1993, 43:509-515.
20. Chong WK, Sweeney B, Wilkinson ID, et al.: Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic and MR imaging findings. Radiology 1993, 188:119-124.
21. Chong WK, Paley M, Wilkinson ID, Hall-Craggs MA, Miller R, Kendall BE: Localised cerebral proton magnetic resonance spectroscopy in HIV infection and AIDS. Am J Neuroradiol 1994, 15:21-25.
22. Barker PB, Lee RR, Mc Arthur JC: AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995, 195:58-64.
23. Paley M, Alonso J, Cozzone PI, et al.: A multi-centre proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retrovirus 1996, 12:213-222.
24. 1H-MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 1994, 12:653-659.
25. Paley M, Wilkinson ID, Hall-Craggs MA, Chong WK, Chinn RJS, Marrison MJG: Short echo lime proton spectroscopy of the brain in HIV infection/AIDS. Magn Reson Imaging 1995, 13:871-875.
26. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36 (suppl 1S):3S-15S.
27. Wilkinson ID, Paley M, Chong WK, et al.: Proton spectroscopy in HIV infection: relaxation limes of cerebral metabolites. Magn Reson Imaging 1994, 12:951-957.
28. Concorde Coordinating Committee: Concorde: MRC/ARNS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. J ancet 1994, 343:871-888.
29. Hall-Craggs MA, Williams I, Wilkinson ID, et al.: Proton spectroscopy in a cross-section of HIV positive asymptomatic patients receiving immediate compared with deferred zidovudine (Concorde study). J NeuroAIDS 1997 (in press).
30. Wilkinson ID, Hall-Craggs MA, Chong WK, et al.: Increase in NA/Cr metabolite ratio following antiretroviral drug therapy in AIDS: a case study. Twelfth Annual Meeting of the Society of Magnetic Resonance in Medicine. Berkelev, August 1993, [abstract 1560].
31. Vion-Dury J, Nicoli F, Salvan A, Confort-Gounv S, Dhiver C Cozzone PJ: Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 1995, 345:60-61.